セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/31 | 1,221 | 1,249 | 1,197 | 1,249 | +28 | +2.3% | 157,900 |
| 2024/01/30 | 1,230 | 1,246 | 1,198 | 1,221 | -9 | -0.7% | 236,700 |
| 2024/01/29 | 1,235 | 1,249 | 1,224 | 1,230 | -8 | -0.6% | 103,200 |
| 2024/01/26 | 1,262 | 1,267 | 1,219 | 1,238 | -27 | -2.1% | 212,500 |
| 2024/01/25 | 1,215 | 1,279 | 1,187 | 1,265 | +50 | +4.1% | 292,500 |
| 2024/01/24 | 1,210 | 1,229 | 1,198 | 1,215 | +21 | +1.8% | 125,300 |
| 2024/01/23 | 1,233 | 1,241 | 1,193 | 1,194 | -15 | -1.2% | 140,400 |
| 2024/01/22 | 1,203 | 1,213 | 1,179 | 1,209 | +3 | +0.2% | 209,200 |
| 2024/01/19 | 1,217 | 1,236 | 1,201 | 1,206 | -16 | -1.3% | 122,600 |
| 2024/01/18 | 1,249 | 1,250 | 1,217 | 1,222 | -18 | -1.5% | 120,900 |
| 2024/01/17 | 1,269 | 1,271 | 1,240 | 1,240 | -52 | -4% | 214,600 |
| 2024/01/16 | 1,314 | 1,331 | 1,290 | 1,292 | -11 | -0.8% | 145,400 |
| 2024/01/15 | 1,282 | 1,308 | 1,260 | 1,303 | +32 | +2.5% | 132,800 |
| 2024/01/12 | 1,274 | 1,278 | 1,240 | 1,271 | -3 | -0.2% | 170,300 |
| 2024/01/11 | 1,280 | 1,282 | 1,254 | 1,274 | +5 | +0.4% | 147,700 |
| 2024/01/10 | 1,286 | 1,308 | 1,268 | 1,269 | -6 | -0.5% | 182,600 |
| 2024/01/09 | 1,278 | 1,300 | 1,258 | 1,275 | ±0 | ±0% | 146,100 |
| 2024/01/05 | 1,301 | 1,306 | 1,270 | 1,275 | -33 | -2.5% | 162,400 |
| 2024/01/04 | 1,252 | 1,308 | 1,230 | 1,308 | +29 | +2.3% | 171,900 |
| 2023/12/29 | 1,266 | 1,300 | 1,258 | 1,279 | -11 | -0.9% | 234,400 |
| 2023/12/28 | 1,240 | 1,290 | 1,201 | 1,290 | +46 | +3.7% | 280,100 |
| 2023/12/27 | 1,187 | 1,267 | 1,184 | 1,244 | +42 | +3.5% | 524,300 |
| 2023/12/26 | 1,235 | 1,258 | 1,200 | 1,202 | -63 | -5% | 519,800 |
| 2023/12/25 | 1,330 | 1,334 | 1,265 | 1,265 | -71 | -5.3% | 432,200 |
| 2023/12/22 | 1,371 | 1,389 | 1,330 | 1,336 | -52 | -3.7% | 237,100 |
| 2023/12/21 | 1,451 | 1,453 | 1,361 | 1,388 | -82 | -5.6% | 357,700 |
| 2023/12/20 | 1,364 | 1,470 | 1,352 | 1,470 | +101 | +7.4% | 474,200 |
| 2023/12/19 | 1,360 | 1,369 | 1,306 | 1,369 | +8 | +0.6% | 448,600 |
| 2023/12/18 | 1,378 | 1,430 | 1,329 | 1,361 | -303 | -18.2% | 1,053,200 |
| 2023/12/15 | 1,623 | 1,686 | 1,587 | 1,664 | +79 | +5% | 393,800 |
| 2023/12/14 | 1,639 | 1,639 | 1,546 | 1,585 | -27 | -1.7% | 374,200 |
| 2023/12/13 | 1,549 | 1,633 | 1,546 | 1,612 | +193 | +13.6% | 771,200 |
| 2023/12/12 | 1,480 | 1,480 | 1,415 | 1,419 | -32 | -2.2% | 194,200 |
| 2023/12/11 | 1,420 | 1,518 | 1,418 | 1,451 | +29 | +2% | 191,300 |
| 2023/12/08 | 1,405 | 1,471 | 1,405 | 1,422 | ±0 | ±0% | 235,700 |
| 2023/12/07 | 1,510 | 1,514 | 1,400 | 1,422 | -101 | -6.6% | 321,700 |
| 2023/12/06 | 1,547 | 1,560 | 1,512 | 1,523 | -24 | -1.6% | 158,200 |
| 2023/12/05 | 1,573 | 1,599 | 1,547 | 1,547 | -38 | -2.4% | 126,100 |
| 2023/12/04 | 1,565 | 1,605 | 1,550 | 1,585 | -16 | -1% | 169,300 |
| 2023/12/01 | 1,585 | 1,645 | 1,580 | 1,601 | +3 | +0.2% | 145,200 |
| 2023/11/30 | 1,652 | 1,709 | 1,584 | 1,598 | -41 | -2.5% | 252,700 |
| 2023/11/29 | 1,631 | 1,658 | 1,592 | 1,639 | +10 | +0.6% | 788,000 |
| 2023/11/28 | 1,612 | 1,639 | 1,564 | 1,629 | -17 | -1% | 305,700 |
| 2023/11/27 | 1,623 | 1,725 | 1,623 | 1,646 | +21 | +1.3% | 215,900 |
| 2023/11/24 | 1,612 | 1,649 | 1,612 | 1,625 | +7 | +0.4% | 179,700 |
| 2023/11/22 | 1,632 | 1,652 | 1,603 | 1,618 | -54 | -3.2% | 269,800 |
| 2023/11/21 | 1,667 | 1,687 | 1,621 | 1,672 | -14 | -0.8% | 212,300 |
| 2023/11/20 | 1,636 | 1,720 | 1,636 | 1,686 | +74 | +4.6% | 297,500 |
| 2023/11/17 | 1,557 | 1,612 | 1,540 | 1,612 | +32 | +2% | 148,100 |
| 2023/11/16 | 1,565 | 1,614 | 1,558 | 1,580 | -4 | -0.3% | 195,200 |
201～
250
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
